A judge has approved a $25 million settlement in a class action against a group of surgeons who worked for the Cosmetic Institute, including a $8.9 million payout for the lawyers that ran the seven-year-old case, saying the deduction from the settlement was reasonable given the “very significant discount” applied to the legal bill.
The plaintiffs in a class action against a group of surgeons who worked for The Cosmetic Institute have told a court that a costs assessment is not necessary to approve a $25 million settlement, which will see $10 million deducted for legal and administrative costs, in light of reductions to the fees.
A group of surgeons who worked for The Cosmetic Institute are set to pay $25 million to settle a class action brought on behalf of 13,500 patients who claim they were injured by botched breast augmentation surgery.
A group of surgeons who worked for The Cosmetic Institute have lost a second bid to declass a representative proceeding on behalf of 13,500 patients who claim they were injured by botched breast augmentation surgery.
Livestock drug company Zoetis has agreed to accept a $2.1 million payout to cover its costs in successfully defending a class action dubbed “totally off the planet” by a judge.
A class action against a group of surgeons who worked for The Cosmetic Institute over allegedly incompetent breast augmentation procedures has been set down for trial over the “loud protest” of the defendants, with a judge choosing to accommodate the plaintiff’s no win, no fee counsel team.
A group of surgeons who worked for The Cosmetic Institute are appealing a judge’s rejection of their bid to declass a representative proceeding on behalf of 13,500 patients who claim they suffered injury or complications from breast augmentation surgery.
A judge has tossed out an application by a group of surgeons who formerly worked for The Cosmetic Institute to declass a representative proceeding on behalf of 13,500 patients who claim they suffered injury or complications from breast augmentation surgery.
Pet and livestock drug company Zoetis, which successfully defended a class action over its horse vaccine Equivac, is pressing forward with its claim against the legal team that ran the unfunded case, seeking to recover $500,000 of its $3.8 million legal bill.
A declassing bid by nine doctors in a class action on behalf of women allegedly injured by a one-size-fits-all approach to breast implant surgeries must apply to the entire proceeding, not just the claims against them, a court has heard.